期刊文献+

MMP-13在早期股骨头坏死滑膜中的表达 被引量:6

Expression of matrix metalloproteinase-13 in synovium of early osteonecrosis of femoral head
下载PDF
导出
摘要 目的分析早期股骨头坏死(ONFH)患者滑膜中基质金属蛋白酶-13(MMP-13)的表达,探讨其在ONFH病情进展中的作用。方法选取30例早期ONFH患者(坏死组)、30例髋关节骨性关节炎(OA)患者(OA组)、30例股骨颈骨折患者(骨折组),术中取滑膜组织,采用免疫组织化学技术检测滑膜中MMP-13蛋白的表达及滑膜形态学改变,并采用RT-PCR技术检测滑膜中MMP-13 mRNA的表达水平。结果免疫组化结果显示,MMP-13蛋白于坏死组及OA组中表达与骨折组中表达差异有统计学意义(P<0.05),而坏死组与OA组间差异无统计学意义(P>0.05);RT-PCR结果显示坏死组与OA组的MMP-13 mRNA表达量差异有统计学意义(P<0.05)。结论 MMP-13蛋白与mRNA在坏死组与OA组中呈高表达,表明两者可能有着相同的滑膜病变机制,但坏死组mRNA表达较OA组更高,表明滑膜病变的程度可能存在差异。 Objective To analyze the expression of matrix metalloproteinase-13 in synovium of early osteonecrosis of femoral head ( ONFH) patients, and to study its effect on progress of ONFH. Methods Selected 30 ONFH patients (osteonecrosis group) , 30 Hip osteoarthritis (OA) patients (OA group) , 30 transcervical fracture patients (fracture group). Synovium dissected in operations. Investigate expressing of MMP-13 protein and morphological change of synovium by immunohistochemical technology. Investigate expressing of MMP-13 mRNA of synovium by RT - PCR technology. Results Immunohistochemistry results showed statistically significant difference in expression of MMP-13 protein in osteonecrosis group and OA group between fracture group (P 〈 0.05). No statiscially significant difference between osteonecrosis group and OA group (P 〉 0.05). RT-PCR results showed statistical significantly difference in expression of MMP-13 mRNA in osteonecrosis group between OA group (P 〈 0. 05). Conclusion High expression of MMP-13 protein in osteonecrosis group and OA group show they may have the same synovial pathological mechanism. Higher expression of MMP-13 mRNA in osteonecrosis group than OA group show the severity of abnormality synovium is different.
出处 《安徽医科大学学报》 CAS 北大核心 2014年第4期502-505,共4页 Acta Universitatis Medicinalis Anhui
关键词 股骨头坏死 滑膜 金属基质蛋白酶-13 免疫组化 RT-PCR osteonecrosis of the femoral head synovium matrix metalloproteinases-13 immunohistochemistry real time-polymerase chain reaction
  • 相关文献

参考文献10

  • 1Rabquer B J, Tan G J, Shaheen P J ,et al. Synovial inflammation in patients with osteonecrosis of the femoral head [J]. Clin Transl Sci, 2009, 2(4) :273 -8.
  • 2Takaishi H, Kimm T ,Dalai S, et al. Joint diseases and matrix metalloproteinases , a role for rMMP-13 [J]. Curt Pham Biotechnol, 2008, 9(1) :47 -54.
  • 3赵德伟,胡永成.成人股骨头坏死诊疗标准专家共识(2012年版)[J].中华关节外科杂志(电子版),2012,6(3):89-92. 被引量:94
  • 4Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis l)[J]. Osteoarthritis Cartilage, 2013, 21(1):16-21.
  • 5Goldring M B, Otero M, Plumb D A, et al. Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP -13 regulation in osteoarthritis [J]. European Cells Material, 2011 , 21 :202 - 20.
  • 6Koskinen A, Vuolteenaho K, Nieminen R,et al. Leptin enhances MMP-l, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients [J]. Clin Exp Rheumatol, 2011 , 29 ( 1): 57 - 64.
  • 7马丽艳,宋旭东,张德新,程潭.MMP-13和Galectin-3在骨性关节炎滑膜组织中的临床意义[J].中国骨与关节杂志,2013,2(5):280-284. 被引量:9
  • 8Sokolove J, Lepus C M. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations [J]. Ther Adv Musculoskelet Dis, 2013, 5(2):77 -94.
  • 9Arnalinei C, Caruntu I D, Giusca S E, et al. Matrix metalloproteinases involvement in pathologic conditions [J]. Rom J Morphol Embryol, 2010, 51(2) :215 -28.
  • 10康鹏德,裴福兴.股骨头坏死的临床分期[J].中华骨科杂志,2010,30(1):25-28. 被引量:17

二级参考文献68

  • 1康鹏德,裴福兴,王坤正.股骨头坏死的宾夕法尼亚大学分期[J].中国矫形外科杂志,2004,12(21):1737-1738. 被引量:18
  • 2赵德伟,王卫明,王本杰,张耀,王铁男,郭林,孙强,芦建民,于晓光.带双血管蒂大转子骨瓣转移治疗股骨头缺血性坏死[J].中华显微外科杂志,2006,29(3):167-169. 被引量:33
  • 3张超,王旭,姜建元,黄煌渊.MMP-1、13 mRNA和DDR2表达与关节软骨退变的关系[J].复旦学报(医学版),2007,34(1):126-128. 被引量:27
  • 4Samuel JP. Niall S. Osteonecrosis of the femoral head: Part 2-options for treatment. Curr Orthop, 2008.22(5): 349-358.
  • 5Mont MA. Jones LC. Hungerrford DS. Nontraunmtic osteonecrosls of the femoral head: ten years later. J Bone Joint Surg (Am), 2006, 88(5): 1117-1132.
  • 6Steinberg ME, Steinberg DR. Classification systems for osteonecrosis: an overview. Orthop Clin North Am, 2004. 35 (3): 273-283.
  • 7Marcus ND, Enneking WF, Massam RA. The silent hip in idiopathic aseptic necrosis. Treatment by bone-grafting. J Bone Joint Surg (Am). 1973, 55(7): 1351-1366.
  • 8Ficat RP. Arlet J. Necrosis of the femoral head//Hungerford DS. ed. Ischemia and necrosis of bone. Bahimore: Williams and Wilkins. 1980: 53-74.
  • 9Steinberg ME, Hayken GD. Steinberg DR. A new method for evaluation and staging of avascular of the femoral head//Arlet J. Fical RP. Hungerford DS. Bone circulalion, Baltimore: Williams and Willkins. 1984: 398-403.
  • 10ARCO (Association Research Circulation Osseous). Committee oll Terminology and Classification. ARCO News, 1992. 4(1): 41-46.

共引文献117

同被引文献73

引证文献6

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部